Dendritic cells, new tools for vaccination

被引:20
作者
Colino, J [1 ]
Snapper, CM [1 ]
机构
[1] Uniformed Serv Univ Hlth Sci, Dept Pathol, Bethesda, MD 20814 USA
关键词
vaccines; immunotherapy; dendritic cells;
D O I
10.1016/S1286-4579(03)00033-9
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Our rapidly expanding knowledge of the biology of the dendritic cell (DC), a major antigen-presenting cell connecting innate and adaptive immunity, suggests new possibilities for the development of vaccines and therapeutic strategies against pathogens, through the manipulation of their function in vivo, or the injection of the DC itself, once properly instructed ex vivo. (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:311 / 319
页数:9
相关论文
共 32 条
[21]   Distinct dendritic cell subsets differentially regulate the class of immune response in vivo [J].
Pulendran, B ;
Smith, JL ;
Caspary, G ;
Brasel, K ;
Pettit, D ;
Maraskovsky, E ;
Maliszewski, CR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (03) :1036-1041
[22]   Dendritic cells pulsed with a recombinant chlamydial major outer membrane protein antigen elicit a CD4+ type 2 rather than type 1 immune response that is not protective [J].
Shaw, J ;
Grund, V ;
Durling, L ;
Crane, D ;
Caldwell, HD .
INFECTION AND IMMUNITY, 2002, 70 (03) :1097-1105
[23]   Heat shock proteins: the 'Swiss Army Knife' vaccines against cancers and infectious agents [J].
Srivastava, PK ;
Amato, RJ .
VACCINE, 2001, 19 (17-19) :2590-2597
[24]   Dynamic imaging of T cell-dendritic cell interactions in lymph nodes [J].
Stoll, S ;
Delon, J ;
Brotz, TM ;
Germain, RN .
SCIENCE, 2002, 296 (5574) :1873-1876
[25]   Exosomes:: Composition, biogenesis and function [J].
Théry, C ;
Zitvogel, L ;
Amigorena, S .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (08) :569-579
[26]   Transport of peptide-MHC class II complexes in developing dendritic cells [J].
Turley, SJ ;
Inaba, K ;
Garrett, WS ;
Ebersold, M ;
Unternaehrer, J ;
Steinman, RM ;
Mellman, I .
SCIENCE, 2000, 288 (5465) :522-527
[27]   Enhanced immunogenicity of BCG vaccine by using a viral-based GM-CSF transgene adjuvant formulation [J].
Wang, J ;
Zganiacz, A ;
Xing, Z .
VACCINE, 2002, 20 (23-24) :2887-2898
[28]  
Williamson E, 1999, J IMMUNOL, V163, P3668
[29]   Maturation stages of mouse dendritic cells in growth factor-dependent long-term cultures [J].
Winzler, C ;
Rovere, P ;
Rescigno, M ;
Granucci, F ;
Penna, G ;
Adorini, L ;
Zimmermann, VS ;
Davoust, J ;
RicciardiCastagnoli, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 185 (02) :317-328
[30]   Enhanced protective antibody responses to PspA after intranasal or subcutaneous injections of PspA genetically fused to granulocyte-macrophage colony-stimulating factor or interleukin-2 [J].
Wortham, C ;
Grinberg, L ;
Kaslow, DC ;
Briles, DE ;
McDaniel, LS ;
Lees, A ;
Flora, M ;
Snapper, CM ;
Mond, JJ .
INFECTION AND IMMUNITY, 1998, 66 (04) :1513-1520